A clinical stage company developing a new class of analgesics.
Location: United States, Texas, Houston
Total raised: $13.3M
Investors 1
| Date | Name | Website |
| - | IrishAngel... | irishangel... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.12.2016 | Series C | $8.2M | - |
| 06.03.2015 | Series B | $5.1M | - |
Mentions in press and media 6
| Date | Title | Description |
| 09.12.2016 | Vapogenix Secures $8.2M in Series C | HOUSTON, TX, Clinical-stage company developing a topical, non-opioid medicine for localized pain, has raised $8.2 million. >> Click here for more funding data on Vapogenix >> To export Vapogenix funding data to PDF and Excel... |
| 08.12.2016 | Vapogenix Raises $8.2m in Funding | Vapogenix, Inc., a Houston, Texas-based developer of non-opioid medicine for localized pain, raised $8.2m in funding. Pamoja Capital, prominent pain physicians and others invested in the round. Vapogenix develops a topical, non-opioid medic... |
| 08.12.2016 | Vapogenix Raises $8.2 Million Series C | HOUSTON, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Vapogenix, Inc., a clinical-stage company developing a topical, non-opioid medicine for localized pain, has raised $8.2 million to advance the development of its lead product, a locally-acting anal... |
| 06.03.2015 | Vapogenix Closes $5.1M in Series B Financing | Vapogenix, Inc., a Houston, TX-based clinical stage pharmaceutical company that is developing a new class of non-narcotic, locally-acting analgesics, completed a $5.1M Series B financing. The round was led by Pamoja Capital and GPG Ventures... |
| 23.12.2014 | Vapogenix gets $2.1M for topical, localized, non-narcotic pain med | “Our core drug goes through skin in five minutes,” Danguole Altman, Vapogenix’s president and CEO, told Xconomy last year. The story continues: The base drug of Vapogenix’s drug are the liquid anesthetics—Altman doesn’t want to get into spe... |
| - | Vapogenix gets $2.1M for topical, localized, non-narcotic pain med | Vapogenix, a Houston pain medicine startup that’s developing a localized analgesic that penetrates the skin quickly, just raised a tidy sum – $2.1 million, according to a regulatory filing. The company won’t say which small molecule drug it... |